HBV infection may reduce the risk of metachronous liver metastasis in postoperative pathological stage 2 colorectal cancer.

MLA

Jiaming, Zhou, et al. “HBV Infection May Reduce the Risk of Metachronous Liver Metastasis in Postoperative Pathological Stage 2 Colorectal Cancer.” International Journal of Colorectal Disease, vol. 35, no. 12, Dec. 2020, pp. 2205–17. EBSCOhost, https://doi.org/10.1007/s00384-020-03712-w.

APA

Jiaming, Z., Pinzhu, H., Xiaoyan, G., Shuyun, T., Rongwan, L., Huanmiao, Z., Xiaofeng, W., Yuanlv, X., Mingzhe, H., Hongen, Y., Meijin, H., & Jianping, W. (2020). HBV infection may reduce the risk of metachronous liver metastasis in postoperative pathological stage 2 colorectal cancer. International Journal of Colorectal Disease, 35(12), 2205–2217. https://doi.org/10.1007/s00384-020-03712-w

Chicago

Jiaming, Zhou, Huang Pinzhu, Guo Xiaoyan, Tan Shuyun, Lin Rongwan, Zhan Huanmiao, Wu Xiaofeng, et al. 2020. “HBV Infection May Reduce the Risk of Metachronous Liver Metastasis in Postoperative Pathological Stage 2 Colorectal Cancer.” International Journal of Colorectal Disease 35 (12): 2205–17. doi:10.1007/s00384-020-03712-w.